Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-25

Clinical Trial Update: A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results suggest that a portion-controlled diet may prevent weight gain in diabetics treated with pioglitazone (Actos).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actos (Pioglitazone)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED